Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ODC1 | P11926 | 2/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.35 |
| ▸ | THRB | P10828 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | PLG | P00747 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.35 |
| ▸ | FDPS | P14324 | 2/20 | 0.35 |
| ▸ | ARG1 | P05089 | 1/20 | 0.35 |
| ▸ | ARG2 | P78540 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27989280 | 1.00 | ODC1 (0.37) | ODC1CYP2D6NFKB1BLMLMNA | |
| SCHEMBL30156940 | 1.00 | ODC1 (0.37) | ODC1CYP2D6NFKB1BLMLMNA | |
| SCHEMBL157457 | 1.00 | ODC1 (0.37) | ODC1CYP2D6NFKB1BLMLMNA | |
| Water SCHEMBL21225404 | 0.98 | ODC1 (0.36) | ODC1CYP2D6NFKB1BLMLMNA | |
| Hydrochloric Acid SCHEMBL21225312 | 0.98 | BLM (0.39) | ODC1CYP2D6NFKB1BLMLMNA | |
| SCHEMBL180302 | 0.94 | ODC1 (0.42) | ODC1CYP2D6NFKB1BLMLMNA | |
| SCHEMBL180301 | 0.94 | ODC1 (0.42) | ODC1CYP2D6NFKB1BLMLMNA | |
| Alpha-Ketoglutaric Acid SCHEMBL2042603 | 0.86 | MAPK1 (0.41) | CYP2D6NFKB1BLMLMNANPSR1 | |
| Alpha-Ketoglutaric Acid SCHEMBL5474736 | 0.86 | MAPK1 (0.41) | CYP2D6NFKB1BLMLMNANPSR1 | |
| Tetradecane SCHEMBL27774110 | 0.85 | DNM1 (0.40) | ODC1KMT2AMEN1ALDH1A1FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2549 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12616761-B2 | CXCR4-targeting compounds | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2026-05-05 | — | — | US | claimed |
| US-20260091067-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | MARVELBIOME INC (US) | 2026-04-02 | — | — | US | claimed |
| US-12560617-B2 | Method of diagnosing and treatment monitoring of crohn's disease and ulcerative colitis | MCMASTER UNIVERSITY (CA) | 2026-02-24 | — | — | US | claimed |
| EP-4619050-A2 | DECREASED RETENTION OF MINIPROTEINS IN KIDNEY | Aktis Oncology, Inc. (US) | 2025-09-24 | — | — | EP | claimed |
| EP-4587116-A2 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | MarvelBiome, Inc. (US) | 2025-07-23 | — | — | EP | claimed |
| WO-2025129285-A1 | COMPOSITIONS AND METHODS FOR IMPROVING PENETRATION OF ACTIVE AGENTS FOR KERATIN FIBERS | L'OREAL (FR) | 2025-06-26 | — | — | WO | claimed |
| WO-2025129284-A1 | COMPOSITIONS AND METHODS FOR TREATING KERATIN FIBERS | L'OREAL (FR) | 2025-06-26 | — | — | WO | claimed |
| WO-2025129294-A1 | METHODS FOR TREATING KERATIN FIBERS WITH OSMOLYTES, CARBOXYLIC ACID AND AMINO ACIDS | L'OREAL (FR) | 2025-06-26 | — | — | WO | claimed |
| WO-2025129291-A1 | METHODS FOR TREATING KERATIN FIBERS WITH OSMOLYTES, CARBOXYLIC ACID AND AMINO ACIDS | L'OREAL (FR) | 2025-06-26 | — | — | WO | claimed |
| WO-2025129296-A1 | METHODS FOR TREATING KERATIN FIBERS WITH OSMOLYTES, CARBOXYLIC ACID AND AMINO ACIDS | L'OREAL (FR) | 2025-06-26 | — | — | WO | claimed |
| WO-2004082628-A2 | IMPROVED BIOAVAILABILITY AND IMPROVED DELIVERY OF ACIDIC PHARMACEUTICAL DRUGS | YU RUEY J (US) | 2004-09-30 | — | — | WO | claimed |
| US-20040166058-A1 | Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2004-08-26 | — | — | US | claimed |
| WO-2004044227-A2 | ETHYLENEDICYSTEINE (EC)-DRUG CONJUGATES, COMPOSITIONS AND METHODS FOR TISSUE SPECIFIC DISEASE IMAGING | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2004-05-27 | — | — | WO | claimed |
| US-20030078231-A1 | Orthomolecular sulpho-adenosylmethionine derivatives with antioxidant properties | WILBURN MICHAEL D (US) | 2003-04-24 | — | — | US | claimed |
| US-20030007961-A1 | Orthomolecular vitamin E derivatives | WILBURN MICHAEL D (US) | 2003-01-09 | — | — | US | claimed |
| EP-0345614-B1 | Amblyommine as an agent for use in antithrombotic therapy | HOECHST AG (DE) | 1994-06-22 | — | — | EP | claimed |
| EP-0345614-A2 | Amblyommine as an agent for use in antithrombotic therapy | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-12-13 | — | — | EP | claimed |
| EP-0091237-B1 | DETERGENT COMPOSITION | AJINOMOTO CO., INC. (JP) | 1986-01-08 | — | — | EP | claimed |
| US-4447356-A | CYCLIC POLYPEPTIDES; MOLLUSC VENOMS; ANTICHOLINERGIC AGENTS; NERVOUS SYSTEM DISORDERS | OLIVERA BALDOMERO M | 1984-05-08 | — | — | US | claimed |
| EP-0091237-A1 | Detergent composition | AJINOMOTO CO., INC. (JP) | 1983-10-12 | — | — | EP | claimed |